ARCHIVES

ASCO’s Lichter Says. Dingell, Stupak Urge FDA To “Act With Due Haste To Avoid Endangering Patients” Steered To ESAs.

This article is from The Cancer Letter archive.

Vol. 34 No. 09 | March 7, 2008

Download PDF Visit The Full Archive

Related Articles

“A significant reduction in the NCI IRP AIDS program may be in order, and released funds should … increase the pool available to extramural research.”

July 21, 1995

Abstracts Of Papers Presented By Breast Cancer Task Force

July 16, 1976

In Brief: LYNNE PENBERTHY Was Named Associate Director For Surveillance Research In NCI’s Division of Cancer Control and Population Sciences

November 8, 2013

Radium Society To Meet In L.A.

March 2, 1979

OHSU Get $500 Million Pledge; Funds to be Matched in Two Years

September 27, 2013

In Brief: ACS to Spend Record $85 Million On Research: AACR To Honor Hanafusa, DeVita, Barbacid

March 14, 1986